Compound‐42 alleviates acute kidney injury by targeting RIPK3‐mediated necroptosis

Xiaoyan He(Anhui Medical University), Xiao‐Ming Meng(Chinese University of Hong Kong, Shenzhen)
British Journal of Pharmacology
May 30, 2023
10.1111/bph.16152
Cited by 23

Related Papers

TGF-β/Smad signaling in renal fibrosis
|Frontiers in Physiology|2015|648
NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation
|Laboratory Investigation|2017|202
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
|Oncotarget|2015|99
Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death
|Laboratory Investigation|2018|52
Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis
|Molecular Therapy|2023|26